These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ, ZEST-AMI Investigators. Am J Cardiol; 2009 Nov 15; 104(10):1370-6. PubMed ID: 19892052 [Abstract] [Full Text] [Related]
5. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Yao ZH, Matsubara T, Inada T, Suzuki Y, Suzuki T. Chin Med J (Engl); 2008 Mar 20; 121(6):503-7. PubMed ID: 18364133 [Abstract] [Full Text] [Related]
8. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography. Tian F, Chen YD, Sun ZJ, Chen L, Yuan F, Song XT, Lü SZ. Chin Med J (Engl); 2009 Mar 20; 122(6):670-4. PubMed ID: 19323932 [Abstract] [Full Text] [Related]
9. Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study. Prati F, Stazi F, Dutary J, La Manna A, Di Giorgio A, Pawlosky T, Gonzalo N, Di Salvo ME, Imola F, Tamburino C, Albertucci M, Alfonso F. Heart; 2011 Nov 20; 97(22):1841-6. PubMed ID: 21880655 [Abstract] [Full Text] [Related]
11. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E. JACC Cardiovasc Interv; 2009 May 20; 2(5):445-52. PubMed ID: 19463469 [Abstract] [Full Text] [Related]
17. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT). Kim JS, Kim BK, Jang IK, Shin DH, Ko YG, Choi D, Hong MK, Cho YK, Nam CW, Hur SH, Choi JH, Song YB, Hahn JY, Choi SH, Gwon HC, Jang Y. Am Heart J; 2012 Apr 20; 163(4):601-7. PubMed ID: 22520526 [Abstract] [Full Text] [Related]
19. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Davlouros PA, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A, Tsigkas G, Alexopoulos D. Int J Cardiol; 2011 Sep 01; 151(2):155-9. PubMed ID: 20605242 [Abstract] [Full Text] [Related]
20. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Guagliumi G, Costa MA, Sirbu V, Musumeci G, Bezerra HG, Suzuki N, Matiashvili A, Lortkipanidze N, Mihalcsik L, Trivisonno A, Valsecchi O, Mintz GS, Dressler O, Parise H, Maehara A, Cristea E, Lansky AJ, Mehran R, Stone GW. Circulation; 2011 Jan 25; 123(3):274-81. PubMed ID: 21220730 [Abstract] [Full Text] [Related] Page: [Next] [New Search]